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Abstract
Background: Preliminary evidence has suggested the role of inflammation in development and prognosis of
cardiovascular diseases and cancers. Most of the prognostic studies failed to account for the effects of co-morbid
conditions as these might have raised the systemic inflammation. We used neutrophil lymphocyte ratio (NLR) as a
measure of systemic inflammation and investigated its association with prevalent chronic conditions.
Methods: Present study is a cross sectional study conducted on population of Karachi, Pakistan. A detailed
questionnaire about the demographic details of all subjects was filled and an informed consent obtained for blood
sampling. Multinomial regression analyses were carried out to investigate the relationship between NLR and
prevalent chronic conditions.
Results: 1070 apparently healthy individuals participated in the study. Proportion of individuals with hypertension
was higher in middle and highest tertile of NLR as compared to the lowest tertile (18.2% & 16.1% compared to
11.8%). Individuals with hypertension were 43% (RRR = 1.43, 95% CI 0.94-2.20) and 66% (RRR = 1.69, 95% CI 1.09-
2.54) more likely to be in the middle and highest tertile of NLR respectively compared to the baseline group.
Similarly, individuals with diabetes mellitus were 53% (RRR = 1.53, 95% CI 0.93-2.51) and 65% (RRR = 1.65, 95% CI
1.01-2.71) more likely to be in the middle or highest tertile of NLR as compared to the baseline NLR group.
Conclusions: Systemic inflammation measured by NLR has a significant association with prevalent chronic
conditions. Future research is needed to investigate this relationship with longitudinal data to establish the
temporal association between these variables.
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Background
Cardiovascular diseases and cancers are leading causes
of morbidity and mortality all over the world. The global
burden of these diseases has sharply increased in last
t w od e c a d e sa n dc o n t i n u e st oa u g m e n td u et ot h e
growth in aging population and health risk behaviours
[1,2]. Preliminary evidence has suggested the role of
inflammation in development and prognosis of cardio-
vascular diseases as well as cancers [3-7].
Several studies have explored the relationship between
systemic inflammation and cardiovascular mortality
[3,5]. Elevated levels of systemic inflammatory markers
have been found associated with incidence of cardiovas-
cular diseases [3,5]. Furthermore, many epidemiological
studies have highlighted that chronic low grade inflam-
mation is associated with diabetes mellitus [8], hyperten-
sion [9], metabolic syndrome [10,11], obesity [12],
smoking [13], and other lifestyle habbits [14].
Systemic inflammation can be measured by using a
variety of biochemical and haematological markers.
Although novel disease specific biomarkers have been
identified, most of which are time consuming and
expensive. Observational studies have thoroughly inves-
tigated the role of C-reactive protein and total leukocyte
count in different chronic conditions [6,7,13,15,16].
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Cell (WBC) count has also been linked to the traditional
risk factors of chronic diseases i.e. smoking, obesity,
hypertension and elevated levels of triglycerides [16,17].
Recent evidence indicated that the ratio of sub types of
blood cells have a significant prognostic value for cardi-
ovascular disease.
Elevated levels of neutrophil lymphocyte ratio (NLR)
were also found associated with poor survival of patients
undergoing coronary artery bypass graft[18]. Many can-
cer survival studies have suggested that NLR is a signifi-
cant predictor of overall and disease specific survival of
patients [19,20]. Whether the systemic inflammation,
which has proven to be a significant predictor of survi-
val of cancer patients, is malignancy associated inflam-
mation or is because of the any co-morbid conditions
that cancer patients may have is still unclear. We
assumed that systemic inflammation might also be
raised in commonly prevalent conditions.
Neutrophil lymphocyte ratio could be an important
measure of systemic inflammation as it is cost effective,
readily available and could be calculated easily. Little is
known and published about neutrophil lymphocyte ratio
and its relationship with prevalent chronic conditions
among general population. Therefore, the current study
was conducted to investigate the neutrophil lymphocyte
ratio as a measure of systemic inflammation and its rela-
tionship, if any, with prevalent chronic diseases.
Methods
This cross sectional study was conducted in the North of
Karachi, the biggest city of Pakistan with a population of
17 millions. We invited 1500 individuals for free medical
check up and participation in this study. The study was
approved by the independent ethics committee. An infor-
mation sheet was prepared in English and Urdu to disse-
minate the objectives of this research study to the
participants and written consent was obtained prior to
employing a self administered questionnaire.
All willing healthy individuals between the ages of 16
to 75 who accepted the invitation to participate were
included in this study. Individuals who visited the hospi-
tal due to current illness or follow up of a previous ill-
ness were excluded. Furthermore, those who had a
smoking habit or used any other addictive substances in
last 12 months were also excluded. We used a pre-
tested self administered questionnaire which included
demographic details, lifestyle habits and history of any
known chronic disease and current and past use of
medications. We also performed a general physical
examination of all participants including height, weight
and blood pressure measurements. Height and weight
were measured removing the shoes, blood pressure was
measured three times with a gap of five minutes and the
mean value was calculated. A trained nurse was avail-
able at the time of examination, and provided support
to participants in filling the questionnaire and in some
cases where they were unable to fill the questionnaire
themselves, she interviewed the participants. We classi-
fied subjects as hypertensive if they had a blood pressure
of greater than 140/90 mm/Hg or those who had been
diagnosed previously. Diabetes mellitus was defined by a
fasting blood glucose level of > 126 mg/dl or a self
report of previously diagnosed diabetes mellitus. Exis-
tence of other chronic conditions (asthma and arthritis)
was ascertained by self reporting.
Investigations
We obtained blood samples of all individuals who parti-
cipated in the study to investigate complete blood
count, lipid profile and fasting blood glucose. We used
Sysmex Pouch counter (An automated machine by S
Ejaz uddin & co) for complete blood count. For com-
plete blood count we took 2 ml of blood in a purple top
vaccutainer (containing ethylene diamine tetra acetic
acid in it in it) and after 5 min mixing on rotator the
sample was ran in machine and results were obtained.
Statistical analysis
We used Stata software version 11 (StataCorp, College
Station, TX, USA) to analyze the collected data. We
grouped the participants in tertiles of neutrophil lym-
phocyte ratios. Tertiles were formed to divide the sam-
ple into three groups of approximately similar number
of participants in each group. Body mass index (BMI)
was calculated by using standard formula of weight in
kilograms divided by height (metres squared). BMI then
categorised into three groups of desirable, overweight
and obese using the recommended cut off for Asian
population, where a BMI of < 23.5 was considered as
desirable, 23.5-27.5 as overweight and > 27.5 as obese
[21]. We calculated the mean and standard deviation for
continuous variables and frequency for categorical vari-
ables. For comparison between groups we used one way
Analysis of Variance (ANOVA) with bonferroni adjust-
ments for multiple comparisons of continuous and
Kruskal Wallis Test for ordinal variables. We used mul-
tinomial logistic regression with lowest category of NLR
as baseline and presented relative risk ratios (RRR). In
multivariate analysis we adjusted for age, gender, BMI
and self reported chronic conditions and taken the first
category as reference. All the significance tests were two
tailed with a significance level 0.05%.
Results
Basic characteristics of study sample
We invited 1500 individuals for this study, 1089
accepted the invitation (response rate 72.6%). Nine
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while blood count data were missing for 10 individuals
so the final analysis included 1070 apparently healthy
individuals. We grouped study sample based on neutro-
phil lymphocyte ratio (NLR) tertiles. Generally, indivi-
duals in the highest tertile o fN L Rw e r es l i g h t l yo l d e r ,
more likely to be male, taller, heavier and obese. How-
e v e r ,t h e r ew a sn os t a t i s t i c a l ly significant difference
between three groups of neutrophil lymphocyte ratio.
Basic characteristics of study sample have been summar-
ized in table 1.
Neutrophil lymphocyte ratio and chronic diseases
Proportion of individuals with hypertension was higher
in middle and highest tertile of NLR as compared to the
lowest tertile (18.2% & 16.1% compared to 11.8%). Simi-
lar trend was observed with diabetes mellitus, while
individuals with asthma and arthritis were more likely to
be in the middle tertile of NLR.
In a model adjusted for other co-morbid conditions,
hypertension and diabetes mellitus were significantly
associated with higher NLR, while asthma and arthritis
did not show any significant association with NLR. Indi-
viduals with hypertension were 43% (RRR = 1.43, 95%
CI 0.94-2.20) and 66% (RRR = 1.69, 95% CI 1.09-2.54)
more likely to be in the middle and highest tertile of
NLR respectively (table 2) compared with baseline
group. Similarly individuals with diabetes mellitus were
53% (RRR = 1.53, 95% CI 0.93-2.51) and 65% (RRR =
1.65, 95% CI 1.01-2.71) more likely to be in the middle
and highest tertile of NLR as compared with baseline
NLR group (table 2). Individuals with asthma and arthri-
tis were 84% and 29% more likely to be in middle tertile
of NLR respectively, however this association was not
statistically significant (table 2).
We further adjusted for the effects of age, gender and
body mass index. In this final multivariate model, NLR
has significant associationw i t hh y p e r t e n s i o na n dd i a -
betes mellitus (Figure 1). Individuals with asthma and
arthritis were more likely to be in the middle group of
NLR tertiles but the association was not significant. Age,
gender and body mass index did not have any significant
association with NLR in final multivariate model (table
3). Furthermore, analysis was also repeated by excluding
hypertensive participants (n = 17) who were taking
other drugs including Statins and/or aspirin but overall
relationship remains consistent and hypertensive indivi-
duals were 56% (RRR 1.56, 95% CI 1.14-2.45, p-value
0.03) more likely to be in the highest tertile of NLR.
Overall relationship between diabetes mellitus and NLR
also remained consistent and significantly differed after
these exclusions. We also categorised the NLR into
quintiles and taken the first category as reference but
this did not materially altered the above mentioned
associations.
Discussion
In this study, we found a significant association between
neutrophil lymphocyte ratio (NLR) and likelihood of
having hypertension and diabetes mellitus. However, we
did not observe a significant relationship between NLR
and asthma or arthritis. These relationships remain
unchanged even after adjusting for age, gender and obe-
sity. Our study confirms that co-morbid conditions are
associated with higher level of systemic inflammation as
measured by NLR. However, we could not explore
whether the low grade inflammation in the body was a
cause of the co-morbid conditions or an effect. Higher
level of white blood cells has been previously linked
with incident hypertension among different population
based studies [9]. Similarly, systemic inflammation has
also been reported as a significant factor for metabolic
syndrome including obesity and diabetes mellitus [11].
Mechanism underlying these associations between sys-
temic inflammation and prevalent conditions remains to
be elucidated. One potential explanation is that, cellular
response of blood components might be mediated
through the endothelial dysfunction. Inflammation
modifies endothelial function and an inability of the
endothelium to produce nitric oxide and prostacyclin
can result in the depletion of vasodilator, antithrombotic
and anti-atherogenic properties of the vascular endothe-
lium[9]. In addition, stimulated leukocytes alter
Table 1 Baseline characteristics of study sample based on
NLR categories
Neutrophil Lymphocyte Ratio,
Tertiles
0.17-1.51 1.52 - <
2.56
2.56 -
22.50
Sample Size 357 361 352
Mean Age (s.d.) 33.4 (15.1) 34.9 (16.1) 33.0 (14.7)
Gender, % (n)
Male 34.6 (207) 31.1 (186) 34.4 (206)
Female 31.9 (150) 37.2 (175) 31.0 (146)
Mean Height (s.d.) 172.1 (9.2) 172.1 (8.8) 173.1 (9.0)
Mean Weight (s.d.) 73.1 (14.1) 72.2 (13.9) 75.9 (14.1)
BMI (kg m
-2), %(n)
< 23.5 (Desirable) 33.4 (134) 37.2 (149) 29.4 (118)
23.5 - 27.5 (Overweight) 34.2 (143) 33.3 (139) 32.5 (136)
> 27.5 (Obese) 32.5 (79) 28.0 (68) 39.5 (96)
Self reported chronic diseases,
%(n)
Hypertension 11.8 (42) 16.1 (58) 18.2 (64)
Diabetes Mellitus 8.1 (29) 11.9 (43) 12.8 (45)
Asthma 3.1 (11) 5.5 (20) 2.8 (10)
Arthritis 7.0 (25) 8.9 (32) 7.4 (26)
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Page 3 of 6Table 2 Relative risk ratio of higher neutrophil lymphocyte ratio (compared to NLR 0.17-1.51)
Neutrophil Lymphocyte Ratio (Tertiles)
1.52-2.56 2.57-22.5
Characteristics Relative Risk Ratio* p value Relative Risk Ratio* p value
(95% CI) (95% CI)
Self reported chronic condition
Hypertension
No 1 1
Yes 1.43 (0.94-2.20) 0.09 1.66 (1.09-2.54) 0.01
Diabetes
No 1 1
Yes 1.53 (0.93-2.51) 0.09 1.65 (1.01-2.71) 0.04
Asthma
No 1 1
Yes 1.84 (0.87-3.90) 0.11 0.92 (0.39-2.19) 0.85
Arthritis
No 1 1
Yes 1.29 (0.70-2.22) 0.36 1.06 (0.60-1.87) 0.84
* Relative risk ratio presented after mutual adjustments of all the covariates presented in the table
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Figure 1 Adjusted relative risk ratio of highest tertile from a multivariate model. Relative risk ratio was adjusted for age, sex, body mass
index and self reported conditions.
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adhere to vascular endothelium and may result in capil-
lary leukocytosis and subsequent increased vascular
resistance[9].
Furthermore, several studies have suggested that
chronic, low grade; subclinical inflammation play a
major role in development of insulin resistance which
may then proceed to development of clinically overt dia-
betes mellitus [8,22]. Risk factors of diabetes mellitus,
such as obesity, smoking and physical inactivity are
associated with chronic low grade inflammation. So this
also explains our findings of a significant relationship
between systemic inflammation and diabetes mellitus.
We did not find any association of inflammatory mar-
kers with asthma and arthritis in this study; this may be
explained by intake of anti-inflammatory medications
among these individuals. Unlike, hypertension and dia-
betes mellitus, both asthma and arthritis can cause sig-
nificant pain and discomfort to individuals which lead
them towards immediate remedy of the symptoms. In
this case, role of inflammation and NLR might have
been masked by the intake of anti-inflammatory and
pain killer drugs.
To our knowledge this is the first study which investi-
gated the role of neutrophil lymphocyte ratio as measure
of systemic inflammation in relation to prevalent
chronic conditions in general population. We have a
reasonable sample and fair number of cases with each
d i s e a s et oe x p l o r ea n yp o s s i ble relationship between
NLR and co-morbid conditions.
There are few limitations of this study which are
worth to be reported. First, we used a cross sectional
design for this study, which is not the best design to
investigate any causal relationships, however this study
does raise some questions whether the systemic inflam-
mation is an effect of chronic condition or is it a cause
of it. Future research with prospective design and multi-
ple measurements of NLR could provide more robust
evidence on role of NLR in relation to co-morbid condi-
tions. Second, it is possible that the relationship between
elevated NLR and co-morbid conditions might have
confounded by some unmeasured co-variates. However,
Table 3 Relative risk ratio of higher neutrophil lymphocyte ratio (compared to NLR 0.17-1.51)
Neutrophil Lymphocyte Ratio (Tertiles)*
1.52-2.56 2.57-22.5
Characteristics Relative Risk Ratio p value Relative Risk Ratio p value
(95% CI) (95% CI)
Age at screening (years)
Age< 40 1 _ 1 _
Age 40-49 1.38 (0.87-2.18) 0.2 1.44 (0.91-2.25) 0.12
Age 50-59 1.19 (0.75-1.89) 0.46 0.66 (0.39-1.11) 0.12
Age 60-75 1.17 (0.69-1.99) 0.56 1.09 (0.64-1.56) 0.75
Gender
Female 1 _ 1 _
Male 0.78 (0.57-1.04) 0.1 1.02 (0.75-1.38) 0.9
Body mass index (kg/m
2)
Desirable, bmi < 23 1 _ 1 _
Overweight, bmi 23-27.5 0.91 (0.65-1.27) 0.56 1.13 (0.80-1.60) 0.47
Obese, bmi > 27.5 0.78 (0.52-1.16) 0.22 1.42 (0.96-2.11) 0.07
Self reported chronic condition
Hypertension
No 1 1
Yes 1.43 (0.93 - 2.20) 0.1 1.69 (1.10 - 2.59) 0.02
Diabetes
No 1 1
Yes 1.38 (0.83-2.29) 0.22 1.72 (1.04-2.85) 0.03
Asthma
No 1 1
Yes 1.53 (0.70-3.34) 0.28 0.89 (0.36-2.21) 0.8
Arthritis
No 1 1
Yes 1.27 (0.73-2.21) 0.4 1.11 (0.62-1.97) 0.73
* Relative risk ratio presented after mutual adjustments of all the covariates presented in the table
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population, this seems unlikely. Finally some element of
bias can not be excluded as individuals with high level
of systemic inflammation are more likely to visit a doc-
tor and this sample might not be a true representative
of the whole population. However, our random invita-
tions might have eliminated some of the effects caused
by chance.
Despite the limitations of the study, we observed that
individuals with prevalent chronic conditions are signifi-
cantly more likely to have higher level of systemic
inflammation and NLR seems a reasonable measure to
detect this condition..
Conclusions
Systemic inflammation measured by NLR has significant
association with prevalent chronic conditions. Future
research needs to investigate the relationship with longi-
tudinal data to establish the temporal relationship
between these.
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